Publications
-
Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules.
Parham P,
Norman PJ, Abi-Rached L, Guethlein LA.
Philos Trans R Soc Lond B Biol Sci.
2012;
367
(1590):
800-11
-
Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3.
Hilton HG,
Vago L, Older Aguilar AM, Moesta AK, Graef T, Abi-Rached L, Norman PJ, Guethlein LA, Fleischhauer K, Parham P.
J Immunol.
2012;
189
(3):
1418-30
-
Natural selection on marine carnivores elaborated a diverse family of classical MHC class I genes exhibiting haplotypic gene content variation and allelic polymorphism.
Hammond JA,
Guethlein LA, Norman PJ, Parham P.
Immunogenetics.
2012;
64
(12):
915-33
-
Review: Immunogenetics of human placentation.
Parham P,
Norman PJ, Abi-Rached L, Hilton HG, Guethlein LA.
Placenta.
2012:
33 Suppl
S71-80
-
Although divergent in residues of the peptide binding site, conserved chimpanzee Patr-AL and polymorphic human HLA-A*02 have overlapping peptide-binding repertoires.
Gleimer M,
Wahl AR, Hickman HD, Abi-Rached L, Norman PJ, Guethlein LA, Hammond JA, Draghi M, Adams EJ, Juo S, Jalili R, Gharizadeh B, Ronaghi M, Garcia KC, Hildebrand WH, Parham P.
J Immunol.
2011;
186
(3):
1575-88
-
Hunter-gatherer genomic diversity suggests a southern African origin for modern humans.
Henn BM,
Gignoux CR, Jobin M, Granka JM, Macpherson JM, Kidd JM, Rodríguez-Botigué L, Ramachandran S, Hon L, Brisbin A, Lin AA, Underhill PA, Comas D, Kidd KK, Norman PJ, Parham P, Bustamante CD, Mountain JL, Feldman MW.
Proc Natl Acad Sci U S A.
2011;
108
(13):
5154-62
-
Natural variation at position 45 in the D1 domain of lineage III killer cell immunoglobulin-like receptors (KIR) has major effects on the avidity and specificity for MHC class I.
Older Aguilar AM,
Guethlein LA, Abi-Rached L, Parham P.
Immunogenetics.
2011;
63
(8):
543-7
-
Rhesus macaque KIR bind human MHC class I with broad specificity and recognize HLA-C more effectively than HLA-A and HLA-B.
Older Aguilar AM,
Guethlein LA, Hermes M, Walter L, Parham P.
Immunogenetics.
2011;
63
(9):
577-85
-
The IMGT/HLA database.
Robinson J,
Mistry K, McWilliam H, Lopez R, Parham P, Marsh SG.
Nucleic Acids Res.
2011;
39
(Database issue):
D1171-6
-
The shaping of modern human immune systems by multiregional admixture with archaic humans.
Abi-Rached L,
Jobin MJ, Kulkarni S, McWhinnie A, Dalva K, Gragert L, Babrzadeh F, Gharizadeh B, Luo M, Plummer FA, Kimani J, Carrington M, Middleton D, Rajalingam R, Beksac M, Marsh SG, Maiers M, Guethlein LA, Tavoularis S, Little AM, Green RE, Norman PJ, Parham P.
Science.
2011;
334
(6052):
89-94
-
Variable NK cell receptors exemplified by human KIR3DL1/S1.
Parham P,
Norman PJ, Abi-Rached L, Guethlein LA.
J Immunol.
2011;
187
(1):
11-9
-
A small, variable, and irregular killer cell Ig-like receptor locus accompanies the absence of MHC-C and MHC-G in gibbons.
Abi-Rached L,
Kuhl H, Roos C, ten Hallers B, Zhu B, Carbone L, de Jong PJ, Mootnick AR, Knaust F, Reinhardt R, Parham P, Walter L.
J Immunol.
2010;
184
(3):
1379-91
-
Coevolution of killer cell Ig-like receptors with HLA-C to become the major variable regulators of human NK cells.
Older Aguilar AM,
Guethlein LA, Adams EJ, Abi-Rached L, Moesta AK, Parham P.
J Immunol.
2010;
185
(7):
4238-51
-
Human-specific evolution and adaptation led to major qualitative differences in the variable receptors of human and chimpanzee natural killer cells.
Abi-Rached L,
Moesta AK, Rajalingam R, Guethlein LA, Parham P.
PLoS Genet.
2010;
6
(11):
e1001192
-
Humans differ from other hominids in lacking an activating NK cell receptor that recognizes the C1 epitope of MHC class I.
Moesta AK,
Graef T, Abi-Rached L, Older Aguilar AM, Guethlein LA, Parham P.
J Immunol.
2010;
185
(7):
4233-7
-
Pregnancy immunogenetics: NK cell education in the womb?
Parham P,
Guethlein LA.
J Clin Invest.
2010;
120
(11):
3801-4
-
Primate-specific regulation of natural killer cells.
Parham P,
Abi-Rached L, Matevosyan L, Moesta AK, Norman PJ, Older Aguilar AM, Guethlein LA.
J Med Primatol.
2010;
39
(4):
194-212
-
Chimpanzees use more varied receptors and ligands than humans for inhibitory killer cell Ig-like receptor recognition of the MHC-C1 and MHC-C2 epitopes.
Moesta AK,
Abi-Rached L, Norman PJ, Parham P.
J Immunol.
2009;
182
(6):
3628-37
-
Co-evolution of KIR2DL3 with HLA-C in a human population retaining minimal essential diversity of KIR and HLA class I ligands.
Gendzekhadze K,
Norman PJ, Abi-Rached L, Graef T, Moesta AK, Layrisse Z, Parham P.
Proc Natl Acad Sci U S A.
2009;
106
(44):
18692-7
-
Dimorphic motifs in D0 and D1+D2 domains of killer cell Ig-like receptor 3DL1 combine to form receptors with high, moderate, and no avidity for the complex of a peptide derived from HIV and HLA-A*2402.
Sharma D,
Bastard K, Guethlein LA, Norman PJ, Yawata N, Yawata M, Pando M, Thananchai H, Dong T, Rowland-Jones S, Brodsky FM, Parham P.
J Immunol.
2009;
183
(7):
4569-82
-
Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.
Cooley S,
Trachtenberg E, Bergemann TL, Saeteurn K, Klein J, Le CT, Marsh SG, Guethlein LA, Parham P, Miller JS, Weisdorf DJ.
Blood.
2009;
113
(3):
726-32
-
Evolution and survival of marine carnivores did not require a diversity of killer cell Ig-like receptors or Ly49 NK cell receptors.
Hammond JA,
Guethlein LA, Abi-Rached L, Moesta AK, Parham P.
J Immunol.
2009;
182
(6):
3618-27
-
KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C.
Graef T,
Moesta AK, Norman PJ, Abi-Rached L, Vago L, Older Aguilar AM, Gleimer M, Hammond JA, Guethlein LA, Bushnell DA, Robinson PJ, Parham P.
J Exp Med.
2009;
206
(11):
2557-72
-
Meiotic recombination generates rich diversity in NK cell receptor genes, alleles, and haplotypes.
Norman PJ,
Abi-Rached L, Gendzekhadze K, Hammond JA, Moesta AK, Sharma D, Graef T, McQueen KL, Guethlein LA, Carrington CV, Chandanayingyong D, Chang YH, Crespí C, Saruhan-Direskeneli G, Hameed K, Kamkamidze G, Koram KA, Layrisse Z, Matamoros N, Milà J, Park MH, Pitchappan RM, Ramdath DD, Shiau MY, Stephens HA, Struik S, Tyan D, Verity DH, Vaughan RW, Davis RW, Fraser PA, Riley EM, Ronaghi M, Parham P.
Genome Res.
2009;
19
(5):
757-69
-
The IMGT/HLA database.
Robinson J,
Waller MJ, Fail SC, McWilliam H, Lopez R, Parham P, Marsh SG.
Nucleic Acids Res.
2009;
37
(Database issue):
D1013-7
-
Analytic approximation of spatial epidemic models of foot and mouth disease.
Parham PE,
Singh BK, Ferguson NM.
Theor Popul Biol.
2008;
73
(3):
349-68
-
MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response.
Yawata M,
Yawata N, Draghi M, Partheniou F, Little AM, Parham P.
Blood.
2008;
112
(6):
2369-80
-
Novel KIR3DL1 alleles and their expression levels on NK cells: convergent evolution of KIR3DL1 phenotype variation?
Thomas R,
Yamada E, Alter G, Martin MP, Bashirova AA, Norman PJ, Altfeld M, Parham P, Anderson SK, McVicar DW, Carrington M.
J Immunol.
2008;
180
(10):
6743-50
-
Polymorphic sites away from the Bw4 epitope that affect interaction of Bw4+ HLA-B with KIR3DL1.
Sanjanwala B,
Draghi M, Norman PJ, Guethlein LA, Parham P.
J Immunol.
2008;
181
(9):
6293-300
-
Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3.
Moesta AK,
Norman PJ, Yawata M, Yawata N, Gleimer M, Parham P.
J Immunol.
2008;
180
(6):
3969-79
-
The evolution of NK cell diversity.
Makrigiannis AP,
Parham P.
Semin Immunol.
2008;
20
(6):
309-10
-
The genetic and evolutionary balances in human NK cell receptor diversity.
Parham P,
Semin Immunol.
2008;
20
(6):
311-6
-
A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature.
Cooley S,
Xiao F, Pitt M, Gleason M, McCullar V, Bergemann TL, McQueen KL, Guethlein LA, Parham P, Miller JS.
Blood.
2007;
110
(2):
578-86
-
Cutting Edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B.
Thananchai H,
Gillespie G, Martin MP, Bashirova A, Yawata N, Yawata M, Easterbrook P, McVicar DW, Maenaka K, Parham P, Carrington M, Dong T, Rowland-Jones S.
J Immunol.
2007;
178
(1):
33-7
-
Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation.
McQueen KL,
Dorighi KM, Guethlein LA, Wong R, Sanjanwala B, Parham P.
Hum Immunol.
2007;
68
(5):
309-23
-
Episodes of natural selection shaped the interactions of IgA-Fc with FcalphaRI and bacterial decoy proteins.
Abi-Rached L,
Dorighi K, Norman PJ, Yawata M, Parham P.
J Immunol.
2007;
178
(12):
7943-54
-
Evolution of killer cell Ig-like receptor (KIR) genes: definition of an orangutan KIR haplotype reveals expansion of lineage III KIR associated with the emergence of MHC-C.
Guethlein LA,
Older Aguilar AM, Abi-Rached L, Parham P.
J Immunol.
2007;
179
(1):
491-504
-
Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells.
O'Connor GM,
Guinan KJ, Cunningham RT, Middleton D, Parham P, Gardiner CM.
J Immunol.
2007;
178
(1):
235-41
-
High-throughput killer cell immunoglobulin-like receptor genotyping by MALDI-TOF mass spectrometry with discovery of novel alleles.
Houtchens KA,
Nichols RJ, Ladner MB, Boal HE, Sollars C, Geraghty DE, Davis LM, Parham P, Trachtenberg EA.
Immunogenetics.
2007;
59
(7):
525-37
-
Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1.
Martin MP,
Qi Y, Gao X, Yamada E, Martin JN, Pereyra F, Colombo S, Brown EE, Shupert WL, Phair J, Goedert JJ, Buchbinder S, Kirk GD, Telenti A, Connors M, O'Brien SJ, Walker BD, Parham P, Deeks SG, McVicar DW, Carrington M.
Nat Genet.
2007;
39
(6):
733-40
-
Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT.
Miller JS,
Cooley S, Parham P, Farag SS, Verneris MR, McQueen KL, Guethlein LA, Trachtenberg EA, Haagenson M, Horowitz MM, Klein JP, Weisdorf DJ.
Blood.
2007;
109
(11):
5058-61
-
NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection.
Draghi M,
Pashine A, Sanjanwala B, Gendzekhadze K, Cantoni C, Cosman D, Moretta A, Valiante NM, Parham P.
J Immunol.
2007;
178
(5):
2688-98
-
The expanded cattle KIR genes are orthologous to the conserved single-copy KIR3DX1 gene of primates.
Guethlein LA,
Abi-Rached L, Hammond JA, Parham P.
Immunogenetics.
2007;
59
(6):
517-22
-
Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans.
Norman PJ,
Abi-Rached L, Gendzekhadze K, Korbel D, Gleimer M, Rowley D, Bruno D, Carrington CV, Chandanayingyong D, Chang YH, Crespí C, Saruhan-Direskeneli G, Fraser PA, Hameed K, Kamkamidze G, Koram KA, Layrisse Z, Matamoros N, Milà J, Park MH, Pitchappan RM, Ramdath DD, Shiau MY, Stephens HA, Struik S, Verity DH, Vaughan RW, Tyan D, Davis RW, Riley EM, Ronaghi M, Parham P.
Nat Genet.
2007;
39
(9):
1092-9
-
Do NK-cell receptors and alloreactivity affect solid organ transplantation?
Vilches C,
Parham P.
Transpl Immunol.
2006;
17
(1):
27-30
-
High KIR diversity in Amerindians is maintained using few gene-content haplotypes.
Gendzekhadze K,
Norman PJ, Abi-Rached L, Layrisse Z, Parham P.
Immunogenetics.
2006;
58
(5-6):
474-80
-
Immunology: adaptable innate killers.
Parham P,
Nature.
2006;
441
(7092):
415-6
-
Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function.
Yawata M,
Yawata N, Draghi M, Little AM, Partheniou F, Parham P.
J Exp Med.
2006;
203
(3):
633-45
-
Taking license with natural killer cell maturation and repertoire development.
Parham P,
Immunol Rev.
2006:
214
155-60
-
The inhibitory receptor NKG2A determines lysis of vaccinia virus-infected autologous targets by NK cells.
Brooks CR,
Elliott T, Parham P, Khakoo SI.
J Immunol.
2006;
176
(2):
1141-7
-
Clathrin heavy and light chain isoforms originated by independent mechanisms of gene duplication during chordate evolution.
Wakeham DE,
Abi-Rached L, Towler MC, Wilbur JD, Parham P, Brodsky FM.
Proc Natl Acad Sci U S A.
2005;
102
(20):
7209-14
-
Complex interactions: the immunogenetics of human leukocyte antigen and killer cell immunoglobulin-like receptors.
Norman PJ,
Parham P.
Semin Hematol.
2005;
42
(2):
65-75
-
Immunogenetics of killer cell immunoglobulin-like receptors.
Parham P,
Mol Immunol.
2005;
42
(4):
459-62
-
Influence of KIR diversity on human immunity.
Parham P,
Adv Exp Med Biol.
2005:
560
47-50
-
KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand.
Carr WH,
Pando MJ, Parham P.
J Immunol.
2005;
175
(8):
5222-9
-
MHC class I molecules and KIRs in human history, health and survival.
Parham P,
Nat Rev Immunol.
2005;
5
(3):
201-14
-
Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues.
Abi-Rached L,
Parham P.
J Exp Med.
2005;
201
(8):
1319-32
-
Nomenclature for factors of the HLA system, 2004.
Marsh SG,
Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Geraghty DE, Hansen JA, Hurley CK, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI, Trowsdale J.
Tissue Antigens.
2005;
65
(4):
301-69
-
Putting a face to MHC restriction.
Parham P,
J Immunol.
2005;
174
(1):
3-5
-
Single haplotype analysis demonstrates rapid evolution of the killer immunoglobulin-like receptor (KIR) loci in primates.
Sambrook JG,
Bashirova A, Palmer S, Sims S, Trowsdale J, Abi-Rached L, Parham P, Carrington M, Beck S.
Genome Res.
2005;
15
(1):
25-35
-
Single-cell analysis of the human NK cell response to missing self and its inhibition by HLA class I.
Draghi M,
Yawata N, Gleimer M, Yawata M, Valiante NM, Parham P.
Blood.
2005;
105
(5):
2028-35
-
Domain shuffling has been the main mechanism forming new hominoid killer cell Ig-like receptors.
Rajalingam R,
Parham P, Abi-Rached L.
J Immunol.
2004;
172
(1):
356-69
-
Immunology. NK cells lose their inhibition.
Parham P,
Science.
2004;
305
(5685):
786-7
-
Killer cell immunoglobulin-like receptor diversity: balancing signals in the natural killer cell response.
Parham P,
Immunol Lett.
2004;
92
(1-2):
11-3
-
Mini-review: defense strategies and immunity-related genes.
Trowsdale J,
Parham P.
Eur J Immunol.
2004;
34
(1):
7-17
-
NK cells and trophoblasts: partners in pregnancy.
Parham P,
J Exp Med.
2004;
200
(8):
951-5
-
T cell-dependent production of IFN-gamma by NK cells in response to influenza A virus.
He XS,
Draghi M, Mahmood K, Holmes TH, Kemble GW, Dekker CL, Arvin AM, Parham P, Greenberg HB.
J Clin Invest.
2004;
114
(12):
1812-9
-
The beta 2-microglobulin locus of rainbow trout (Oncorhynchus mykiss) contains three polymorphic genes.
Magor KE,
Shum BP, Parham P.
J Immunol.
2004;
172
(6):
3635-43
-
Activation of a subset of human NK cells upon contact with Plasmodium falciparum-infected erythrocytes.
Artavanis-Tsakonas K,
Eleme K, McQueen KL, Cheng NW, Parham P, Davis DM, Riley EM.
J Immunol.
2003;
171
(10):
5396-405
-
Alloreactive killer cells: hindrance and help for haematopoietic transplants.
Parham P,
McQueen KL.
Nat Rev Immunol.
2003;
3
(2):
108-22
-
Cloning and sequencing full-length HLA-B and -C genes.
Cox ST,
McWhinnie AJ, Robinson J, Marsh SG, Parham P, Madrigal JA, Little AM.
Tissue Antigens.
2003;
61
(1):
20-48
-
Human KIR sequences 2003.
Garcia CA,
Robinson J, Guethlein LA, Parham P, Madrigal JA, Marsh SG.
Immunogenetics.
2003;
55
(4):
227-39
-
IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex.
Robinson J,
Waller MJ, Parham P, de Groot N, Bontrop R, Kennedy LJ, Stoehr P, Marsh SG.
Nucleic Acids Res.
2003;
31
(1):
311-4
-
Immunogenetics of killer-cell immunoglobulin-like receptors.
Parham P,
Tissue Antigens.
2003;
62
(3):
194-200
-
Innate immunity: The unsung heroes.
Parham P,
Nature.
2003;
423
(6935):
20
-
Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002.
Marsh SG,
Parham P, Dupont B, Geraghty DE, Trowsdale J, Middleton D, Vilches C, Carrington M, Witt C, Guethlein LA, Shilling H, Garcia CA, Hsu KC, Wain H.
Immunogenetics.
2003;
55
(4):
220-6
-
Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002.
Marsh SG,
Parham P, Dupont B, Geraghty DE, Trowsdale J, Middleton D, Vilches C, Carrington M, Witt C, Guethlein LA, Shilling H, Garcia CA, Hsu KC, Wain H.
Tissue Antigens.
2003;
62
(1):
79-86
-
Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation.
Shilling HG,
McQueen KL, Cheng NW, Shizuru JA, Negrin RS, Parham P.
Blood.
2003;
101
(9):
3730-40
-
Stress management: MHC class I and class I-like molecules as reporters of cellular stress.
Gleimer M,
Parham P.
Immunity.
2003;
19
(4):
469-77
-
The protein made from a common allele of KIR3DL1 (3DL1*004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1.
Pando MJ,
Gardiner CM, Gleimer M, McQueen KL, Parham P.
J Immunol.
2003;
171
(12):
6640-9
-
A human genome diversity cell line panel.
Cann HM,
de Toma C, Cazes L, Legrand MF, Morel V, Piouffre L, Bodmer J, Bodmer WF, Bonne-Tamir B, Cambon-Thomsen A, Chen Z, Chu J, Carcassi C, Contu L, Du R, Excoffier L, Ferrara GB, Friedlaender JS, Groot H, Gurwitz D, Jenkins T, Herrera RJ, Huang X, Kidd J, Kidd KK, Langaney A, Lin AA, Mehdi SQ, Parham P, Piazza A, Pistillo MP, Qian Y, Shu Q, Xu J, Zhu S, Weber JL, Greely HT, Feldman MW, Thomas G, Dausset J, Cavalli-Sforza LL.
Science.
2002;
296
(5566):
261-2
-
Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype.
Shilling HG,
Guethlein LA, Cheng NW, Gardiner CM, Rodriguez R, Tyan D, Parham P.
J Immunol.
2002;
168
(5):
2307-15
-
Conservation and variation in human and common chimpanzee CD94 and NKG2 genes.
Shum BP,
Flodin LR, Muir DG, Rajalingam R, Khakoo SI, Cleland S, Guethlein LA, Uhrberg M, Parham P.
J Immunol.
2002;
168
(1):
240-52
-
Definition of gene content for nine common group B haplotypes of the Caucasoid population: KIR haplotypes contain between seven and eleven KIR genes.
Uhrberg M,
Parham P, Wernet P.
Immunogenetics.
2002;
54
(4):
221-9
-
Distinctive KIR and HLA diversity in a panel of north Indian Hindus.
Rajalingam R,
Krausa P, Shilling HG, Stein JB, Balamurugan A, McGinnis MD, Cheng NW, Mehra NK, Parham P.
Immunogenetics.
2002;
53
(12):
1009-19
-
Genetic control of human NK cell repertoire.
Shilling HG,
Young N, Guethlein LA, Cheng NW, Gardiner CM, Tyan D, Parham P.
J Immunol.
2002;
169
(1):
239-47
-
KIR: diverse, rapidly evolving receptors of innate and adaptive immunity.
Vilches C,
Parham P.
Annu Rev Immunol.
2002:
20
217-51
-
Linkage of Patr-AL to Patr-A and- B in the major histocompatibility complex of the common chimpanzee (Pan troglodytes).
Geller R,
Adams EJ, Guethlein LA, Little AM, Madrigal JA, Parham P.
Immunogenetics.
2002;
54
(3):
212-5
-
NK cell receptors of the orangutan (Pongo pygmaeus): a pivotal species for tracking the coevolution of killer cell Ig-like receptors with MHC-C.
Guethlein LA,
Flodin LR, Adams EJ, Parham P.
J Immunol.
2002;
169
(1):
220-9
-
NK cell-mediated lysis of autologous HCMV-infected skin fibroblasts is highly variable among NK cell clones and polyclonal NK cell lines.
Carr WH,
Little AM, Mocarski E, Parham P.
Clin Immunol.
2002;
105
(2):
126-40
-
Nomenclature for factors of the HLA system, 2002.
Marsh SG,
Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Geraghty DE, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf E, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI.
Tissue Antigens.
2002;
60
(5):
407-64
-
Predominance of group A KIR haplotypes in Japanese associated with diverse NK cell repertoires of KIR expression.
Yawata M,
Yawata N, McQueen KL, Cheng NW, Guethlein LA, Rajalingam R, Shilling HG, Parham P.
Immunogenetics.
2002;
54
(8):
543-50
-
Some human KIR haplotypes contain two KIR2DL5 genes: KIR2DL5A and KIR2DL5B.
Gómez-Lozano N,
Gardiner CM, Parham P, Vilches C.
Immunogenetics.
2002;
54
(5):
314-9
-
Structures of two major histocompatibility complex class I genes of the rainbow trout (Oncorhynchus mykiss).
Shum BP,
Mason PM, Magor KE, Flodin LR, Stet RJ, Parham P.
Immunogenetics.
2002;
54
(3):
193-9
-
The D0 domain of KIR3D acts as a major histocompatibility complex class I binding enhancer.
Khakoo SI,
Geller R, Shin S, Jenkins JA, Parham P.
J Exp Med.
2002;
196
(7):
911-21
-
Variable receptors controlling activation and inhibition of NK cells.
McQueen KL,
Parham P.
Curr Opin Immunol.
2002;
14
(5):
615-21
-
Variation within the human killer cell immunoglobulin-like receptor (KIR) gene family.
Yawata M,
Yawata N, Abi-Rached L, Parham P.
Crit Rev Immunol.
2002;
22
(5-6):
463-82
-
Conserved organization of the ILT/LIR gene family within the polymorphic human leukocyte receptor complex.
Young NT,
Canavez F, Uhrberg M, Shum BP, Parham P.
Immunogenetics.
2001 May-Jun;
53
(4):
270-8
-
A novel, nonclassical MHC class I molecule specific to the common chimpanzee.
Adams EJ,
Cooper S, Parham P.
J Immunol.
2001;
167
(7):
3858-69
-
Comparison of chimpanzee and human leukocyte Ig-like receptor genes reveals framework and rapidly evolving genes.
Canavez F,
Young NT, Guethlein LA, Rajalingam R, Khakoo SI, Shum BP, Parham P.
J Immunol.
2001;
167
(10):
5786-94
-
Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism.
Gardiner CM,
Guethlein LA, Shilling HG, Pando M, Carr WH, Rajalingam R, Vilches C, Parham P.
J Immunol.
2001;
166
(5):
2992-3001
-
Differential expression of leukocyte receptor complex-encoded Ig-like receptors correlates with the transition from effector to memory CTL.
Young NT,
Uhrberg M, Phillips JH, Lanier LL, Parham P.
J Immunol.
2001;
166
(6):
3933-41
-
Exon 5 encoding the transmembrane region of HLA-A contains a transitional region for the induction of nonsense-mediated mRNA decay.
Watanabe Y,
Magor KE, Parham P.
J Immunol.
2001;
167
(12):
6901-11
-
Genomic analysis of common chimpanzee major histocompatibility complex class I genes.
Adams EJ,
Parham P.
Immunogenetics.
2001;
53
(3):
200-8
-
IMGT/HLA Database--a sequence database for the human major histocompatibility complex.
Robinson J,
Waller MJ, Parham P, Bodmer JG, Marsh SG.
Nucleic Acids Res.
2001;
29
(1):
210-3
-
Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors.
Rajalingam R,
Gardiner CM, Canavez F, Vilches C, Parham P.
Tissue Antigens.
2001;
57
(1):
22-31
-
Modes of salmonid MHC class I and II evolution differ from the primate paradigm.
Shum BP,
Guethlein L, Flodin LR, Adkison MA, Hedrick RP, Nehring RB, Stet RJ, Secombes C, Parham P.
J Immunol.
2001;
166
(5):
3297-308
-
New nomenclature for MHC receptors.
André P,
Biassoni R, Colonna M, Cosman D, Lanier LL, Long EO, Lopez-Botet M, Moretta A, Moretta L, Parham P, Trowsdale J, Vivier E, Wagtmann N, Wilson MJ.
Nat Immunol.
2001;
2
(8):
661
-
Nomenclature for factors of the HLA system, 2000.
Marsh SG,
Bodmer JG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI.
Tissue Antigens.
2001;
57
(3):
236-83
-
Short KIR haplotypes in pygmy chimpanzee (Bonobo) resemble the conserved framework of diverse human KIR haplotypes.
Rajalingam R,
Hong M, Adams EJ, Shum BP, Guethlein LA, Parham P.
J Exp Med.
2001;
193
(1):
135-46
-
Species-specific evolution of MHC class I genes in the higher primates.
Adams EJ,
Parham P.
Immunol Rev.
2001:
183
41-64
-
The repertoire of killer cell Ig-like receptor and CD94:NKG2A receptors in T cells: clones sharing identical alpha beta TCR rearrangement express highly diverse killer cell Ig-like receptor patterns.
Uhrberg M,
Valiante NM, Young NT, Lanier LL, Phillips JH, Parham P.
J Immunol.
2001;
166
(6):
3923-32
-
Common chimpanzees have greater diversity than humans at two of the three highly polymorphic MHC class I genes.
Adams EJ,
Cooper S, Thomson G, Parham P.
Immunogenetics.
2000;
51
(6):
410-24
-
Discovery of two novel variants of KIR2DS5 reveals this gene to be a common component of human KIR 'B' haplotypes.
Vilches C,
Pando MJ, Rajalingam R, Gardiner CM, Parham P.
Tissue Antigens.
2000;
56
(5):
453-6
-
Distinguishing recombination and intragenic gene conversion by linkage disequilibrium patterns.
Wiehe T,
Mountain J, Parham P, Slatkin M.
Genet Res.
2000;
75
(1):
61-73
-
Gene structure and promoter variation of expressed and nonexpressed variants of the KIR2DL5 gene.
Vilches C,
Gardiner CM, Parham P.
J Immunol.
2000;
165
(11):
6416-21
-
Genes encoding human killer-cell Ig-like receptors with D1 and D2 extracellular domains all contain untranslated pseudoexons encoding a third Ig-like domain.
Vilches C,
Pando MJ, Parham P.
Immunogenetics.
2000;
51
(8-9):
639-46
-
IMGT/HLA database--a sequence database for the human major histocompatibility complex.
Robinson J,
Malik A, Parham P, Bodmer JG, Marsh SG.
Tissue Antigens.
2000;
55
(3):
280-7
-
KIR2DL5, a novel killer-cell receptor with a D0-D2 configuration of Ig-like domains.
Vilches C,
Rajalingam R, Uhrberg M, Gardiner CM, Young NT, Parham P.
J Immunol.
2000;
164
(11):
5797-804
-
MHC I-dependent antigen presentation is inhibited by poliovirus protein 3A.
Deitz SB,
Dodd DA, Cooper S, Parham P, Kirkegaard K.
Proc Natl Acad Sci U S A.
2000;
97
(25):
13790-5
-
NK cell receptors: of missing sugar and missing self.
Parham P,
Curr Biol.
2000;
10
(5):
R195-7
-
Rapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humans.
Khakoo SI,
Rajalingam R, Shum BP, Weidenbach K, Flodin L, Muir DG, Canavez F, Cooper SL, Valiante NM, Lanier LL, Parham P.
Immunity.
2000;
12
(6):
687-98
-
A divergent non-classical class I gene conserved in salmonids.
Shum BP,
Rajalingam R, Magor KE, Azumi K, Carr WH, Dixon B, Stet RJ, Adkison MA, Hedrick RP, Parham P.
Immunogenetics.
1999;
49
(6):
479-90
-
Analysis of a successful immune response against hepatitis C virus.
Cooper S,
Erickson AL, Adams EJ, Kansopon J, Weiner AJ, Chien DY, Houghton M, Parham P, Walker CM.
Immunity.
1999;
10
(4):
439-49
-
Evidence for an HLA-C-like locus in the orangutan Pongo pygmaeus.
Adams EJ,
Thomson G, Parham P.
Immunogenetics.
1999;
49
(10):
865-71
-
Evolutionary disruptions of human syntenic groups 3, 12, 14, and 15 in Ateles paniscus chamek (Platyrrhini, primates).
Canavez FC,
Moreira MA, Bonvicino CR, Parham P, Seuánez HN.
Cytogenet Cell Genet.
1999;
87
(3-4):
182-8
-
Hepatitis C virus envelope glycoprotein E1 originates in the endoplasmic reticulum and requires cytoplasmic processing for presentation by class I MHC molecules.
Selby M,
Erickson A, Dong C, Cooper S, Parham P, Houghton M, Walker CM.
J Immunol.
1999;
162
(2):
669-76
-
Immunogenetics. Soaring costs in defence.
Parham P,
Nature.
1999;
401
(6756):
870-1
-
Molecular phylogeny of new world primates (Platyrrhini) based on beta2-microglobulin DNA sequences.
Canavez FC,
Moreira MA, Ladasky JJ, Pissinatti A, Parham P, Seuánez HN.
Mol Phylogenet Evol.
1999;
12
(1):
74-82
-
Nomenclature for factors of the HLA system, 1998.
Bodmer JG,
Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI.
Tissue Antigens.
1999;
53
(4 Pt 2):
407-46
-
Phylogenetic relationships of the Callitrichinae (Platyrrhini, primates) based on beta2-microglobulin DNA sequences.
Canavez FC,
Moreira MA, Simon F, Parham P, Seuánez HN.
Am J Primatol.
1999;
48
(3):
225-36
-
Polymorphism and evolution of HLA class I and II genes and molecules.
Little AM,
Parham P.
Rev Immunogenet.
1999;
1
(1):
105-23
-
Population frequencies and putative haplotypes of the killer cell immunoglobulin-like receptor sequences and evidence for recombination.
Witt CS,
Dewing C, Sayer DC, Uhrberg M, Parham P, Christiansen FT.
Transplantation.
1999;
68
(11):
1784-9
-
Residue 3 of beta2-microglobulin affects binding of class I MHC molecules by the W6/32 antibody.
Ladasky JJ,
Shum BP, Canavez F, Seuánez HN, Parham P.
Immunogenetics.
1999;
49
(4):
312-20
-
Virtual reality in the MHC.
Parham P,
Immunol Rev.
1999:
167
5-15
-
Evidence for recombination as a mechanism for KIR diversification.
Shilling HG,
Lienert-Weidenbach K, Valiante NM, Uhrberg M, Parham P.
Immunogenetics.
1998 Nov-Dec;
48
(6):
413-6
-
A major histocompatibility complex class I allele shared by two species of chimpanzee.
Cooper S,
Adams EJ, Wells RS, Walker CM, Parham P.
Immunogenetics.
1998;
47
(3):
212-7
-
CK-1, a putative chemokine of rainbow trout (Oncorhynchus mykiss).
Dixon B,
Shum B, Adams EJ, Magor KE, Hedrick RP, Muir DG, Parham P.
Immunol Rev.
1998:
166
341-8
-
Characterization of chimpanzee TCRV gene polymorphism: how old are human TCRV alleles?
Jaeger EE,
Bontrop RE, Parham P, Wickings EJ, Kadwell M, Lanchbury JS.
Immunogenetics.
1998;
47
(2):
115-23
-
Clathrin self-assembly is regulated by three light-chain residues controlling the formation of critical salt bridges.
Ybe JA,
Greene B, Liu SH, Pley U, Parham P, Brodsky FM.
EMBO J.
1998;
17
(5):
1297-303
-
Comparative gene assignment in Ateles paniscus chamek (Platyrrhini, Primates) and man: association of three separate human syntenic groups and evolutionary considerations.
Canavez F,
Moreira MA, Bonvicino CR, Parham P, Seuánez HN.
Chromosoma.
1998;
107
(2):
73-9
-
Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition.
Winter CC,
Gumperz JE, Parham P, Long EO, Wagtmann N.
J Immunol.
1998;
161
(2):
571-7
-
HLA class I region sequences, 1998.
Mason PM,
Parham P.
Tissue Antigens.
1998;
51
(4 Pt 2):
417-66
-
The Bw4/Bw6 difference between HLA-B*0802 and HLA-B*0801 changes the peptides endogenously bound and the stimulation of alloreactive T cells.
Arnett KL,
Huang W, Valiante NM, Barber LD, Parham P.
Immunogenetics.
1998;
48
(1):
56-61
-
The influence of exogenous peptide on beta2-microglobulin exchange in the HLA complex: analysis in real-time.
Morgan CL,
Ruprai AK, Solache A, Lowdell M, Price CP, Cohen SB, Parham P, Madrigal JA, Newman DJ.
Immunogenetics.
1998;
48
(2):
98-107
-
beta2-Microglobulin in neotropical primates (Platyrrhini).
Canavez FC,
Ladasky JJ, Muniz JA, Seuánez HN, Parham P, Cavanez C.
Immunogenetics.
1998;
48
(2):
133-40
-
Events in the adaptation of natural killer cell receptors to MHC class I polymorphisms.
Parham P,
Res Immunol.
1997 Mar-Apr;
148
(3):
190-4
-
A new HLA-B44 variant (B44BO [B*4408]) identified by serology.
Darke C,
Street J, Fussell H, Thomas M, Guttridge M, Goldberg TE, Arnett KL, Parham P.
Tissue Antigens.
1997;
50
(1):
32-7
-
Assignment of TCF1, TGM1, CALM1, CKB, THBS1, B2M, and FES in Ateles paniscus chamek (Platyrrhini, Primates).
Moreira MA,
Canavez F, Parham P, Seuánez HN.
Cytogenet Cell Genet.
1997;
79
(1-2):
92-6
-
Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor.
Gumperz JE,
Barber LD, Valiante NM, Percival L, Phillips JH, Lanier LL, Parham P.
J Immunol.
1997;
158
(11):
5237-41
-
Cw*1701 defines a divergent african HLA-C allelic lineage.
Wells RS,
Seielstad MT, Bunce M, Tyan DB, Bekele E, Parham P.
Immunogenetics.
1997;
46
(3):
173-80
-
Episodic evolution and turnover of HLA-B in the indigenous human populations of the Americas.
Parham P,
Arnett KL, Adams EJ, Little AM, Tees K, Barber LD, Marsh SG, Ohta T, Markow T, Petzl-Erler ML.
Tissue Antigens.
1997;
50
(3):
219-32
-
Filling in the blanks.
Parham P,
Tissue Antigens.
1997;
50
(4):
318-21
-
Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors.
Valiante NM,
Uhrberg M, Shilling HG, Lienert-Weidenbach K, Arnett KL, D'Andrea A, Phillips JH, Lanier LL, Parham P.
Immunity.
1997;
7
(6):
739-51
-
HLA class I genotyping by cDNA sequence of a Vietnamese family expressing a weak B46 antigen.
Tzeng CM,
Percival L, Barber LD, Cooper S, Adams EJ, Stewart D, Parham P.
Tissue Antigens.
1997;
49
(5):
519-22
-
Human diversity in killer cell inhibitory receptor genes.
Uhrberg M,
Valiante NM, Shum BP, Shilling HG, Lienert-Weidenbach K, Corliss B, Tyan D, Lanier LL, Parham P.
Immunity.
1997;
7
(6):
753-63
-
Interactions of HLA-B*4801 with peptide and CD8.
Martinez-Naves E,
Barber LD, Madrigal JA, Vullo CM, Clayberger C, Lyu SC, Williams RC, Gorodezky C, Markow T, Petzl-Erler ML, Parham P.
Tissue Antigens.
1997;
50
(3):
258-64
-
Killer cell receptors: keeping pace with MHC class I evolution.
Valiante NM,
Lienert K, Shilling HG, Smits BJ, Parham P.
Immunol Rev.
1997:
155
155-64
-
Mismatches for two major and one minor histocompatibility antigen correlate with a patient's rejection of a bone marrow graft from a serologically HLA-identical sibling.
Lienert-Weidenbach K,
Valiante NM, Brown C, White C, Johnston-Dow L, McGinnis M, Krausa P, Lakes DM, Wolf JL, Blume KG, Parham P.
Biol Blood Marrow Transplant.
1997;
3
(5):
255-60
-
Natural inactivation of a common HLA allele (A*2402) has occurred on at least three separate occasions.
Magor KE,
Taylor EJ, Shen SY, Martinez-Naves E, Valiante NM, Wells RS, Gumperz JE, Adams EJ, Little AM, Williams F, Middleton D, Gao X, McCluskey J, Parham P, Lienert-Weidenbach K.
J Immunol.
1997;
158
(11):
5242-50
-
Natural killer cells, HLA class I molecules, and marrow transplantation.
Valiante NM,
Parham P.
Biol Blood Marrow Transplant.
1997;
3
(5):
229-35
-
Nomenclature for factors of the HLA system, 1996.
Bodmer JG,
Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Charron D, Dupont B, Erlich HA, Fauchet R, Mach B, Mayr WR, Parham P, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI.
Tissue Antigens.
1997;
49
(3 Pt 2):
297-321
-
Polymorphism in the alpha 1 helix of the HLA-B heavy chain can have an overriding influence on peptide-binding specificity.
Barber LD,
Percival L, Arnett KL, Gumperz JE, Chen L, Parham P.
J Immunol.
1997;
158
(4):
1660-9
-
Putting a hold on "HLA-H'. The WHO Nomenclature Committee for Factors of the HLA System.
Bodmer JG,
Parham P, Albert ED, Marsh SG.
Nat Genet.
1997;
15
(3):
234-5
-
A novel recombinant HLA-B*39 allele (B*3910) in a South African Zulu.
Wells RS,
Parham P.
Tissue Antigens.
1996;
48
(5):
595-7
-
B27 polymorphism and peptide repertoire.
Parham P,
Clin Rheumatol.
1996:
15 Suppl 1
72-3
-
CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B, and HLA-C allotypes.
Phillips JH,
Chang C, Mattson J, Gumperz JE, Parham P, Lanier LL.
Immunity.
1996;
5
(2):
163-72
-
Characterization of the peptide-binding specificity of HLA-B*7301.
Barber LD,
Percival L, Parham P.
Tissue Antigens.
1996;
47
(6):
472-7
-
Evolution of MHC class I genes in higher primates.
Lienert K,
Parham P.
Immunol Cell Biol.
1996;
74
(4):
349-56
-
Functions for MHC class I carbohydrates inside and outside the cell.
Parham P,
Trends Biochem Sci.
1996;
21
(11):
427-33
-
HLA-A *2607: sequence of a novel A*26 subtype predicted by DNA typing which shares the MA2.1 epitope with A*02, B*57 and B*58.
Arnett KL,
Moses JH, Williams F, Marsh SG, Bodmer JG, Parham P, Middleton D.
Tissue Antigens.
1996;
47
(5):
422-5
-
HLA-C typing of eleven Papua New Guineans: identification of an HLA-Cw4/Cw2 hybrid allele.
Little AM,
Mason A, Marsh SG, Parham P.
Tissue Antigens.
1996;
48
(2):
113-7
-
Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibililty complex haplotype.
Gumperz JE,
Valiante NM, Parham P, Lanier LL, Tyan D.
J Exp Med.
1996;
183
(4):
1817-27
-
Immunology: keeping mother at bay.
Parham P,
Curr Biol.
1996;
6
(6):
638-41
-
Killer cell inhibitory receptor recognition of human leukocyte antigen (HLA) class I blocks formation of a pp36/PLC-gamma signaling complex in human natural killer (NK) cells.
Valiante NM,
Phillips JH, Lanier LL, Parham P.
J Exp Med.
1996;
184
(6):
2243-50
-
NK cells and CTL: opposite sides of the same coin.
Valiante NM,
Parham P.
Chem Immunol.
1996:
64
146-63
-
On the sequence of A*3101.
Arnett KL,
Adams EJ, Parham P.
Tissue Antigens.
1996;
47
(5):
428-30
-
Patr-A and B, the orthologues of HLA-A and B, present hepatitis C virus epitopes to CD8+ cytotoxic T cells from two chronically infected chimpanzees.
Kowalski H,
Erickson AL, Cooper S, Domena JD, Parham P, Walker CM.
J Exp Med.
1996;
183
(4):
1761-75
-
Peptides bound endogenously by HLA-Cw*0304 expressed in LCL 721.221 cells include a peptide derived from HLA-E.
Tzeng CM,
Adams EJ, Gumperz JE, Percival L, Wells RS, Parham P, Barber LD.
Tissue Antigens.
1996;
48
(4 Pt 1):
325-8
-
Pictures of MHC restriction.
Parham P,
Nature.
1996;
384
(6605):
109-10
-
Population biology of antigen presentation by MHC class I molecules.
Parham P,
Ohta T.
Science.
1996;
272
(5258):
67-74
-
Presentation of HLA class I-derived peptides: potential involvement in allorecognition and HLA-B27-associated arthritis.
Parham P,
Immunol Rev.
1996:
154
137-54
-
Response: peopling the americas.
Parham P,
Science.
1996;
273
(5276):
724-5
-
Specificity of two anti-class I HLA monoclonal antibodies that block class I recognition by the NKB1 killer cell inhibitory receptor.
Gumperz JE,
Paterson JC, Litwin V, Valiante N, Lanier LL, Parham P, Little AM.
Tissue Antigens.
1996;
48
(4 Pt 1):
278-84
-
The inter-locus recombinant HLA-B*4601 has high selectivity in peptide binding and functions characteristic of HLA-C.
Barber LD,
Percival L, Valiante NM, Chen L, Lee C, Gumperz JE, Phillips JH, Lanier LL, Bigge JC, Parekh RB, Parham P.
J Exp Med.
1996;
184
(2):
735-40
-
The presence of HLA-A*2403 and HLA-B*1512 on the same haplotype in a Thai family.
Chandanayingyong D,
Adams EJ, Arnett KL, Hildebrand WH, Parham P, Lau M.
Tissue Antigens.
1996;
47
(5):
426-7
-
The presentation of a hepatitis C viral peptide by distinct major histocompatibility complex class I allotypes from two chimpanzee species.
Cooper S,
Kowalski H, Erickson AL, Arnett K, Little AM, Walker CM, Parham P.
J Exp Med.
1996;
183
(2):
663-8
-
Unexpected beta2-microglobulin sequence diversity in individual rainbow trout.
Shum BP,
Azumi K, Zhang S, Kehrer SR, Raison RL, Detrich HW, Parham P.
Proc Natl Acad Sci U S A.
1996;
93
(7):
2779-84
-
Unusual uniformity of the N-linked oligosaccharides of HLA-A, -B, and -C glycoproteins.
Barber LD,
Patel TP, Percival L, Gumperz JE, Lanier LL, Phillips JH, Bigge JC, Wormwald MR, Parekh RB, Parham P.
J Immunol.
1996;
156
(9):
3275-84
-
Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones.
Biassoni R,
Falco M, Cambiaggi A, Costa P, Verdiani S, Pende D, Conte R, Di Donato C, Parham P, Moretta L.
J Exp Med.
1995;
182
(2):
605-9
-
Antibody structure. The duck's dilemma.
Parham P,
Nature.
1995;
374
(6517):
16-7
-
Antigen presentation by class I major histocompatibility complex molecules: a context for thinking about HLA-G.
Parham P,
Am J Reprod Immunol.
1995;
34
(1):
10-9
-
Definition of a new HLA-B7 subtype (B*0704) by isoelectric focusing, family studies and DNA sequence analysis.
Kubens BS,
Arnett KL, Adams EJ, Parham P, Grosse-Wilde H.
Tissue Antigens.
1995;
45
(5):
322-7
-
Dissociation of beta 2-microglobulin from HLA class I heavy chains correlates with acquisition of epitopes in the cytoplasmic tail.
Little AM,
Nössner E, Parham P.
J Immunol.
1995;
154
(10):
5205-15
-
Evolutionary immunology. A boost to immunity from nurse sharks.
Parham P,
Curr Biol.
1995;
5
(7):
696-9
-
Expression of an unusual Bw4 epitope by a subtype of HLA-B8 [B*0802].
Arnett KL,
Adams EJ, Gumperz JE, Darke C, Marsh SG, Gelsthorpe K, Parham P.
Tissue Antigens.
1995;
46
(4):
316-21
-
HLA class I nucleotide sequences, 1995.
Arnett KL,
Parham P.
Tissue Antigens.
1995;
46
(3 ( Pt 2)):
217-57
-
HLA-B16 antigens: sequence of the ST-16 antigen, further definition of two B38 subtypes and evidence for convergent evolution of B*3902.
Adams EJ,
Martinez-Naves E, Arnett KL, Little AM, Tyan DB, Parham P.
Tissue Antigens.
1995;
45
(1):
18-26
-
Homogeneity of allelic sequence for serological variants of HLA-B53.
Adams EJ,
Scott I, Shah A, Arnett KL, Marsh SG, Madrigal JA, Parham P.
Tissue Antigens.
1995;
46
(4):
330-2
-
Identification of a novel HLA-B40 allele (B*4008) in a patient with leukemia.
Adams EJ,
Little AM, Arnett KL, Leushner J, Parham P.
Tissue Antigens.
1995;
46
(3 ( Pt 1)):
204-5
-
Low HLA-C expression at cell surfaces correlates with increased turnover of heavy chain mRNA.
McCutcheon JA,
Gumperz J, Smith KD, Lutz CT, Parham P.
J Exp Med.
1995;
181
(6):
2085-95
-
On the nucleotide sequences of B*2702 and B*2705.
Moses JH,
Marsh SG, Arnett KL, Adams EJ, Bodmer JG, Parham P.
Tissue Antigens.
1995;
46
(1):
50-3
-
Overlap in the repertoires of peptides bound in vivo by a group of related class I HLA-B allotypes.
Barber LD,
Gillece-Castro B, Percival L, Li X, Clayberger C, Parham P.
Curr Biol.
1995;
5
(2):
179-90
-
Species-specific differences in chaperone interaction of human and mouse major histocompatibility complex class I molecules.
Nössner E,
Parham P.
J Exp Med.
1995;
181
(1):
327-37
-
Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes.
Phillips JH,
Gumperz JE, Parham P, Lanier LL.
Science.
1995;
268
(5209):
403-5
-
The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor.
Gumperz JE,
Litwin V, Phillips JH, Lanier LL, Parham P.
J Exp Med.
1995;
181
(3):
1133-44
-
The NKB1 and HP-3E4 NK cells receptors are structurally distinct glycoproteins and independently recognize polymorphic HLA-B and HLA-C molecules.
Lanier LL,
Gumperz JE, Parham P, Melero I, López-Botet M, Phillips JH.
J Immunol.
1995;
154
(7):
3320-7
-
The enigma of the natural killer cell.
Gumperz JE,
Parham P.
Nature.
1995;
378
(6554):
245-8
-
The interaction of calmodulin with clathrin-coated vesicles, triskelions, and light chains. Localization of a binding site.
Pley UM,
Hill BL, Alibert C, Brodsky FM, Parham P.
J Biol Chem.
1995;
270
(5):
2395-402
-
The origins of HLA-A,B,C polymorphism.
Parham P,
Adams EJ, Arnett KL.
Immunol Rev.
1995:
143
141-80
-
Three new HLA-B alleles found in Mexican-Americans.
Adams EJ,
Little AM, Arnett KL, McAuley JE, Williams RC, Parham P.
Tissue Antigens.
1995;
46
(5):
414-16
-
A small test of a sequence-based typing method: definition of the B*1520 allele.
Domena JD,
Little AM, Arnett KL, Adams EJ, Marsh SG, Parham P.
Tissue Antigens.
1994;
44
(4):
217-24
-
ASHI Rose Payne Lecture. Of Payne, polymorphism, and populations.
Parham P,
Hum Immunol.
1994;
40
(2):
77-92
-
Alloantibodies can discriminate three populations of HLA-B40 molecules encoded by B*4002.
Domena JD,
Arnett KL, Marsh SG, Bodmer JG, Parham P.
Tissue Antigens.
1994;
44
(1):
57-8
-
Functional polymorphism in class I major histocompatibility complex genes.
Parham P,
Soc Gen Physiol Ser.
1994:
49
93-103
-
HLA-B15: a widespread and diverse family of HLA-B alleles.
Hildebrand WH,
Domena JD, Shen SY, Lau M, Terasaki PI, Bunce M, Marsh SG, Guttridge MG, Bias WB, Parham P.
Tissue Antigens.
1994;
43
(4):
209-18
-
HLA-B67: a member of the HLA-B16 family that expresses the ME1 epitope.
Little AM,
Domena JD, Hildebrand WH, Shen SY, Barber LD, Marsh SG, Bias WB, Parham P.
Tissue Antigens.
1994;
43
(1):
38-43
-
Peptides corresponding to the CD8 and CD4 binding domains of HLA molecules block T lymphocyte immune responses in vitro.
Clayberger C,
Lyu SC, DeKruyff R, Parham P, Krensky AM.
J Immunol.
1994;
153
(3):
946-51
-
Structure of a novel subtype of B7 (B*0705) isolated from a Chinese individual.
Arnett KL,
Adams EJ, Domena JD, Parham P.
Tissue Antigens.
1994;
44
(5):
318-21
-
T-cell selection. Accentuating the positive.
Parham P,
Curr Biol.
1994;
4
(5):
444-7
-
The HLA-B73 antigen has a most unusual structure that defines a second lineage of HLA-B alleles.
Parham P,
Arnett KL, Adams EJ, Barber LD, Domena JD, Stewart D, Hildebrand WH, Little AM.
Tissue Antigens.
1994;
43
(5):
302-13
-
The HLA-B7Qui antigen is encoded by a new subtype of HLA-B27 (B*2708).
Hildebrand WH,
Domena JD, Shen SY, Marsh SG, Bunce M, Guttridge MG, Darke C, Parham P.
Tissue Antigens.
1994;
44
(1):
47-51
-
The essence of epitopes.
Barber LD,
Parham P.
J Exp Med.
1994;
180
(4):
1191-4
-
The rise and fall of great class I genes.
Parham P,
Semin Immunol.
1994;
6
(6):
373-82
-
A sixth family of HLA-A alleles defined by HLA-A*8001.
Domena JD,
Hildebrand WH, Bias WB, Parham P.
Tissue Antigens.
1993;
42
(3):
156-9
-
B*1401 encodes the B64 antigen: the B64 and B65 splits of B14 differ only at residue 11, a buried amino acid.
Domena JD,
Azumi K, Bias WB, Parham P.
Tissue Antigens.
1993;
41
(2):
110-1
-
Clathrin: its role in receptor-mediated vesicular transport and specialized functions in neurons.
Pley U,
Parham P.
Crit Rev Biochem Mol Biol.
1993;
28
(5):
431-64
-
Disease resistance: good news from Gambia.
Parham P,
Curr Biol.
1993;
3
(4):
223-5
-
HLA Class I nucleotide sequences, 1992.
Zemmour J,
Parham P.
Immunobiology.
1993;
187
(1-2):
70-101
-
HLA class I nucleotide sequences, 1992.
Zemmour J,
Parham P.
Immunogenetics.
1993;
37
(4):
239-50
-
HLA class I nucleotide sequences, 1992.
Zemmour J,
Parham P.
Eur J Immunogenet.
1993;
20
(1):
29-45
-
HLA, anthropology, and transplantation.
Parham P,
Transplant Proc.
1993;
25
(1 Pt 1):
159-61
-
Peptide binding to major histocompatibility complex molecules.
Barber LD,
Parham P.
Annu Rev Cell Biol.
1993:
9
163-206
-
Peptides corresponding to the CD8 binding region of HLA class I block the differentiation of cytotoxic T lymphocyte precursors.
Krensky AM,
Lyu SC, Pouletty P, Benjamin R, Parham P, Clayberger C.
Transplant Proc.
1993;
25
(1 Pt 1):
483-4
-
Primary structure shows HLA-B59 to be a hybrid of HLA-B55 and HLA-B51, and not a subtype of HLA-B8.
Hildebrand WH,
Domena JD, Parham P.
Tissue Antigens.
1993;
41
(4):
190-5
-
Structural heterogeneity in HLA-B70, a high-frequency antigen of black populations.
Domena JD,
Little AM, Madrigal AJ, Hildebrand WH, Johnston-Dow L, du Toit E, Bias WB, Parham P.
Tissue Antigens.
1993;
42
(5):
509-17
-
A ribosomal protein-like sequence in the 3' untranslated region of the HLA-F gene.
Zemmour J,
Parham P.
Tissue Antigens.
1992;
40
(5):
250-3
-
Anchoring pockets in human histocompatibility complex leukocyte antigen (HLA) class I molecules: analysis of the conserved B ("45") pocket of HLA-B27.
Buxton SE,
Benjamin RJ, Clayberger C, Parham P, Krensky AM.
J Exp Med.
1992;
175
(3):
809-20
-
Distinctive polymorphism at the HLA-C locus: implications for the expression of HLA-C.
Zemmour J,
Parham P.
J Exp Med.
1992;
176
(4):
937-50
-
HLA class I nucleotide sequences, 1992.
Zemmour J,
Parham P.
Hum Immunol.
1992;
34
(4):
225-41
-
HLA class I nucleotide sequences, 1992.
Zemmour J,
Parham P.
Tissue Antigens.
1992;
40
(5):
221-8
-
HLA-B27 and disease: a consequence of inadvertent antigen presentation?
Benjamin R,
Parham P.
Rheum Dis Clin North Am.
1992;
18
(1):
11-21
-
HLA-Bw22: a family of molecules with identity to HLA-B7 in the alpha 1-helix.
Hildebrand WH,
Madrigal JA, Little AM, Parham P.
J Immunol.
1992;
148
(4):
1155-62
-
Molecular definition of an elusive third HLA-A9 molecule: HLA-A9.3.
Little AM,
Madrigal JA, Parham P.
Immunogenetics.
1992;
35
(1):
41-5
-
Polymorphic specificity of Q1/28, a monoclonal antibody that preferentially reacts with free class I heavy chains.
Benjamin RJ,
Abrams JR, Parnes JR, Madrigal JA, Parham P.
Immunogenetics.
1992;
37
(1):
73-6
-
Reptilian class I major histocompatibility complex genes reveal conserved elements in class I structure.
Grossberger D,
Parham P.
Immunogenetics.
1992;
36
(3):
166-74
-
Serologic cross-reactivities poorly reflect allelic relationships in the HLA-B12 and HLA-B21 groups. Dominant epitopes of the alpha 2 helix.
Hildebrand WH,
Madrigal JA, Belich MP, Zemmour J, Ward FE, Williams RC, Parham P.
J Immunol.
1992;
149
(11):
3563-8
-
Structure of CD8 alpha and beta chains of the orangutan: novel patterns of mRNA splicing encoding hingeless polypeptides.
Lawlor DA,
Parham P.
Immunogenetics.
1992;
36
(2):
121-5
-
The B*4002 allele encodes the B61 antigen: B40* is identical to B61.
Domena JD,
Johnston-Dow L, Parham P.
Tissue Antigens.
1992;
40
(5):
254-6
-
The HLA-A,B "negative" mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon.
Zemmour J,
Little AM, Schendel DJ, Parham P.
J Immunol.
1992;
148
(6):
1941-8
-
The molecular basis for reactivity of anti-Cw1 and anti-Cw3 alloantisera with HLA-B46 haplotypes.
Zemmour J,
Gumperz JE, Hildebrand WH, Ward FE, Marsh SG, Williams RC, Parham P.
Tissue Antigens.
1992;
39
(5):
249-57
-
Typing for class I HLA polymorphism: past, present, and future.
Parham P,
Eur J Immunogenet.
1992;
19
(5):
347-59
-
Unusual HLA-B alleles in two tribes of Brazilian Indians.
Belich MP,
Madrigal JA, Hildebrand WH, Zemmour J, Williams RC, Luz R, Petzl-Erler ML, Parham P.
Nature.
1992;
357
(6376):
326-9
-
The pros and cons of polymorphism: a brighter future for cheetahs?
Parham P,
Res Immunol.
1991 Jun-Aug;
142
(5-6):
447-8
-
A stressful relationship.
Parham P,
Trends Biochem Sci.
1991;
16
(10):
357-8
-
Ancient HLA genes from 7,500-year-old archaeological remains.
Lawlor DA,
Dickel CD, Hauswirth WW, Parham P.
Nature.
1991;
349
(6312):
785-8
-
Evolution of class I major histocompatibility complex genes and molecules in humans and apes.
Parham P,
Lawlor DA.
Hum Immunol.
1991;
30
(2):
119-28
-
Gorilla class I major histocompatibility complex alleles: comparison to human and chimpanzee class I.
Lawlor DA,
Warren E, Taylor P, Parham P.
J Exp Med.
1991;
174
(6):
1491-509
-
HLA class I nucleotide sequences, 1991.
Zemmour J,
Parham P.
Immunobiology.
1991;
182
(3-4):
347-67
-
HLA class I nucleotide sequences, 1991.
Zemmour J,
Parham P.
Tissue Antigens.
1991;
37
(4):
174-80
-
HLA class I nucleotide sequences, 1991.
Zemmour J,
Parham P.
Immunogenetics.
1991;
33
(5-6):
310-20
-
HLA class I nucleotide sequences, 1991.
Zemmour J,
Parham P.
Hum Immunol.
1991;
31
(3):
195-206
-
HLA class I nucleotide sequences, 1991.
Zemmour J,
Parham P.
Eur J Immunogenet.
1991;
18
(4):
279-89
-
Molecular definition of a polymorphic antigen (LA45) of free HLA-A and -B heavy chains found on the surfaces of activated B and T cells.
Madrigal JA,
Belich MP, Benjamin RJ, Little AM, Hildebrand WH, Mann DL, Parham P.
J Exp Med.
1991;
174
(5):
1085-95
-
Peptide binding to empty HLA-B27 molecules of viable human cells.
Benjamin RJ,
Madrigal JA, Parham P.
Nature.
1991;
351
(6321):
74-7
-
The HLA-Bw75 subtype of B15: molecular characterization and comparison with crossreacting antigens.
Little AM,
Parham P.
Tissue Antigens.
1991;
38
(4):
186-90
-
A binding site for the T-cell co-receptor CD8 on the alpha 3 domain of HLA-A2.
Salter RD,
Benjamin RJ, Wesley PK, Buxton SE, Garrett TP, Clayberger C, Krensky AM, Norment AM, Littman DR, Parham P.
Nature.
1990;
345
(6270):
41-6
-
Apparent lack of MHC restriction in binding of class I HLA molecules to solid-phase peptides.
Chen BP,
Rothbard J, Parham P.
J Exp Med.
1990;
172
(3):
931-6
-
Comparison of class I MHC alleles in humans and apes.
Lawlor DA,
Warren E, Ward FE, Parham P.
Immunol Rev.
1990:
113
147-85
-
Conservation and diversity in families of coated vesicle adaptins.
Ponnambalam S,
Robinson MS, Jackson AP, Peiperl L, Parham P.
J Biol Chem.
1990;
265
(9):
4814-20
-
Cytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule.
Chen BP,
Madrigal A, Parham P.
J Exp Med.
1990;
172
(3):
779-88
-
Evolution of class-I MHC genes and proteins: from natural selection to thymic selection.
Lawlor DA,
Zemmour J, Ennis PD, Parham P.
Annu Rev Immunol.
1990:
8
23-63
-
Guilt by association: HLA-B27 and ankylosing spondylitis.
Benjamin R,
Parham P.
Immunol Today.
1990;
11
(4):
137-42
-
HLA-AR, an inactivated antigen-presenting locus related to HLA-A. Implications for the evolution of the MHC.
Zemmour J,
Koller BH, Ennis PD, Geraghty DE, Lawlor DA, Orr HT, Parham P.
J Immunol.
1990;
144
(9):
3619-29
-
Rapid cloning of HLA-A,B cDNA by using the polymerase chain reaction: frequency and nature of errors produced in amplification.
Ennis PD,
Zemmour J, Salter RD, Parham P.
Proc Natl Acad Sci U S A.
1990;
87
(7):
2833-7
-
Recognition of an HLA public determinant (Bw4) by human allogeneic cytotoxic T lymphocytes.
Clayberger C,
Rosen M, Parham P, Krensky AM.
J Immunol.
1990;
144
(11):
4172-6
-
Recognition of antigen and alloantigen by T cells: a common mechanism?
Parham P,
Trends Biochem Sci.
1990;
15
(3):
79-81
-
Structure of class-I MHC molecules: HLA-B27 and disease.
Parham P,
Scand J Rheumatol Suppl.
1990:
87
11-20
-
T-lymphocyte-antigen interactions in transplant rejection.
Krensky AM,
Weiss A, Crabtree G, Davis MM, Parham P.
N Engl J Med.
1990;
322
(8):
510-7
-
Uncoating protein (hsc70) binds a conformationally labile domain of clathrin light chain LCa to stimulate ATP hydrolysis.
DeLuca-Flaherty C,
McKay DB, Parham P, Hill BL.
Cell.
1990;
62
(5):
875-87
-
Direct binding of influenza peptides to class I HLA molecules.
Chen BP,
Parham P.
Nature.
1989;
337
(6209):
743-5
-
Diversity and diversification of HLA-A,B,C alleles.
Parham P,
Lawlor DA, Lomen CE, Ennis PD.
J Immunol.
1989;
142
(11):
3937-50
-
Diversity of class I HLA molecules: functional and evolutionary interactions with T cells.
Parham P,
Benjamin RJ, Chen BP, Clayberger C, Ennis PD, Krensky AM, Lawlor DA, Littman DR, Norment AM, Orr HT.
Cold Spring Harb Symp Quant Biol.
1989:
54 Pt 1
529-43
-
HLA-B51 and HLA-Bw52 differ by only two amino acids which are in the helical region of the alpha 1 domain.
Hayashi H,
Ennis PD, Ariga H, Salter RD, Parham P, Kano K, Takiguchi M.
J Immunol.
1989;
142
(1):
306-11
-
Mutually exclusive public epitopes of HLA-A,B,C molecules.
Salter RD,
Parham P.
Hum Immunol.
1989;
26
(2):
85-9
-
Polymorphism in the alpha 3 domain of HLA-A molecules affects binding to CD8.
Salter RD,
Norment AM, Chen BP, Clayberger C, Krensky AM, Littman DR, Parham P.
Nature.
1989;
338
(6213):
345-7
-
The occurrence of disulphide bonds in purified clathrin light chains.
Parham P,
Brodsky FM, Drickamer K.
Biochem J.
1989;
257
(3):
775-81
-
Function and polymorphism of human leukocyte antigen-A,B,C molecules.
Parham P,
Am J Med.
1988;
85
(6A):
2-5
-
HLA-A and B polymorphisms predate the divergence of humans and chimpanzees.
Lawlor DA,
Ward FE, Ennis PD, Jackson AP, Parham P.
Nature.
1988;
335
(6187):
268-71
-
Identification of the phosphorylation sites of clathrin light chain LCb.
Hill BL,
Drickamer K, Brodsky FM, Parham P.
J Biol Chem.
1988;
263
(12):
5499-501
-
Molecular cloning of bovine class I MHC cDNA.
Ennis PD,
Jackson AP, Parham P.
J Immunol.
1988;
141
(2):
642-51
-
Nature of polymorphism in HLA-A, -B, and -C molecules.
Parham P,
Lomen CE, Lawlor DA, Ways JP, Holmes N, Coppin HL, Salter RD, Wan AM, Ennis PD.
Proc Natl Acad Sci U S A.
1988;
85
(11):
4005-9
-
Structure of human clathrin light chains. Conservation of light chain polymorphism in three mammalian species.
Jackson AP,
Parham P.
J Biol Chem.
1988;
263
(32):
16688-95
-
HLA-A2 peptides can regulate cytolysis by human allogeneic T lymphocytes.
Clayberger C,
Parham P, Rothbard J, Ludwig DS, Schoolnik GK, Krensky AM.
Nature.
1987 Dec 24-31;
330
(6150):
763-5
-
Functional sites of human class I MHC molecules: paradigms a dozen?
Parham P,
Immunol Res.
1987;
6
(3):
153-78
-
Localization of an epitope of beta-2 microglobulin that is shared with other members of the immunoglobulin superfamily.
Parham P,
Lutz PM, Cresswell P.
Immunogenetics.
1987;
26
(4-5):
323-6
Help